BiotechTube

AGS-1C4D4 + Gemcitabine

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Carcinoma, Pancreatic Ductal

Conditions

Carcinoma, Pancreatic Ductal, Pancreatic Cancer, Pancreatic Disease

Trial Timeline

Apr 1, 2009 → Apr 1, 2012

NCT ID
NCT00902291

About AGS-1C4D4 + Gemcitabine

AGS-1C4D4 + Gemcitabine is a phase 2 stage product being developed by Astellas Pharma for Carcinoma, Pancreatic Ductal. The current trial status is completed. This product is registered under clinical trial identifier NCT00902291. Target conditions include Carcinoma, Pancreatic Ductal, Pancreatic Cancer, Pancreatic Disease.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT01608711Phase 2Completed
NCT00902291Phase 2Completed

Competing Products

20 competing products in Carcinoma, Pancreatic Ductal

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
NRC-2694-A + PaclitaxelNatco PharmaPhase 2
51
Sintilimab + Nab paclitaxel + CisplatinCSPC Pharmaceutical Group LimitedPhase 2
51
Autologous Mesothelin-specific TCR-T Cells + Cyclophosphamide + Fludarabine + BendamustineLonzaPhase 1
30
Pemetrexed + CarboplatinEli LillyPhase 3
77
PRGN-3005 UltraCAR-T cells + PRGN-3005 UltraCAR-T cellsPrecigenPhase 1
28
Cemiplimab + CetuximabEli LillyPhase 2
52
IMC-1121B (ramucirumab) + Oxaliplatin + Folinic acid + 5-FU + 5-FUEli LillyPhase 2
52
[203Pb]Pb-PSV359 + [212Pb]Pb-PSV359Perspective TherapeuticsPhase 1/2
33
CT-01 + EVEROLIMUSCaptor TherapeuticsPhase 1
25
BB-401Benitec BiopharmaPhase 2
44
Zentalis + GemzarZentalis PharmaceuticalsPhase 2
44
AzenosertibZentalis PharmaceuticalsPhase 2
44
6-Thio-2'-Deoxyguanosine + CemiplimabMAIA BiotechnologyPhase 2
44
6-Thio-2'-Deoxyguanosine + Cemiplimab + Docetaxel + Vinorelbine + Gemcitabine aloneMAIA BiotechnologyPhase 3
69
ateganosine + CadonilimabMAIA BiotechnologyPhase 1
25
gemcitabine + carboplatin + cisplatinEli LillyPhase 2
52
CetuximabEli LillyPhase 1
33
Ramucirumab + PaclitaxelEli LillyPhase 2
52
LY2875358 + ErlotinibEli LillyPhase 2
52

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85